Nanovery is developing nanorobots to diagnose the world's deadliest diseases.
Nanovery has raised $1.4M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in April 2025.
Nanovery's investors include SFC Capital, Northstar Ventures, Innovate UK, North East Fund, Earlymarket.
Nanovery is headquartered in Newcastle Upon Tyne, United Kingdom.
Nanovery is developing nanorobots to diagnose the world's deadliest diseases.
Nanovery is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Nanovery — Funding & Investors." VCBacked, April 10, 2025, https://www.vcbacked.co/company/nanovery. Accessed September 2, 2026.
VCBacked. (2025). Nanovery — Funding & Investors. Retrieved September 2, 2026, from https://www.vcbacked.co/company/nanovery
{{cite web |title=Nanovery — Funding & Investors |url=https://www.vcbacked.co/company/nanovery |website=VCBacked |access-date=September 2, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated